# ACETAMINOPHEN
> **ANDA216617** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2022-07-27
## Drug
- **FDA Application Number:** ANDA216617
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN
- **Generic name:** ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2022-07-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216617)
---
*MORVS · CC0 1.0*